explore -WSS

explore

author：leisure time 2025-09-06 01:57:31 - browse：2

A sign of Humana insurance company on a brick building — business coverage from STAT — Adobe

Medicare Advantage beneficiaries on Tuesday filed a class-action lawsuit alleging that the health insurance giant Humana illegally used an algorithm to prematurely cut off payment for rehabilitation care after patients suffered serious illnesses and injuries.

The suit, filed in U.S. District Court in Western Kentucky, argues Humana’s reliance on the algorithm, known as nH Predict, was part of a fraudulent scheme to reap a windfall by systematically denying claims to desperately ill people.

It is the second suit filed following a STAT investigation that found Medicare Advantage insurers nationwide are using the algorithm to cut off patients’ rehab care, forcing them to forgo treatment or pay thousands of dollars out of pocket. An earlier complaint was filed in November against the algorithm’s maker, NaviHealth, and the company that owns NaviHealth, UnitedHealth Group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Doctor appointment wait times are getting worse

leisure time

knowledge

WSS

7 people shot in DC, police say

Rep. Raul Ruiz on the physician shortage and more

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Takeda, Janssen join wearable maker to measure scratching

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

How to pay for weight loss drugs and save Medicare

hotspot

explore

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Can food be medicine? And other questions about a new push

The high cost of giving birth even with insurance

Inside the fall of star MIT scientist David Sabatini

Wildfire smoke exposes gaps in outdoor worker protections

Grail is spending more than ever lobbying Congress

As demand for Covid shots wanes, Moderna seeks its next success

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Moonlake's readout produced a cash windfall. Risks remain

Flagship Pioneering launches a new biotech in two countries

hotspot

7 people shot in DC, police say

Listen: Biogen's messy board & Laronde's data problem

Pediatric cancer treatments threatened by a new FDA policy

Did the public have the right to know Arthur Ashe had AIDS?

Organ aging and disease risk measured by new blood test

What don’t we know about an Alzheimer’s drug side effect?

explore

leisure time

knowledge

hotspot